| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Animals | 117 | 2024 | 735 | 5.570 |
Why?
|
| Bone Regeneration | 24 | 2023 | 33 | 5.380 |
Why?
|
| Bone and Bones | 28 | 2024 | 48 | 4.420 |
Why?
|
| Prostheses and Implants | 25 | 2021 | 39 | 4.290 |
Why?
|
| Femur | 47 | 2021 | 65 | 3.950 |
Why?
|
| Bone Density | 34 | 2022 | 49 | 3.930 |
Why?
|
| Osteogenesis | 23 | 2023 | 36 | 3.620 |
Why?
|
| Male | 92 | 2023 | 1041 | 3.500 |
Why?
|
| Bone Remodeling | 18 | 2021 | 30 | 3.350 |
Why?
|
| X-Ray Microtomography | 19 | 2023 | 37 | 2.800 |
Why?
|
| Rats | 43 | 2021 | 155 | 2.370 |
Why?
|
| Female | 49 | 2024 | 971 | 2.360 |
Why?
|
| Osteolysis | 7 | 2020 | 17 | 2.360 |
Why?
|
| Bone Matrix | 6 | 2017 | 9 | 2.250 |
Why?
|
| Disease Models, Animal | 16 | 2024 | 98 | 2.140 |
Why?
|
| Humans | 74 | 2024 | 1892 | 2.060 |
Why?
|
| Osseointegration | 16 | 2021 | 24 | 2.050 |
Why?
|
| Wnt Signaling Pathway | 3 | 2021 | 7 | 1.960 |
Why?
|
| Osteoporosis | 7 | 2021 | 16 | 1.930 |
Why?
|
| Rats, Sprague-Dawley | 32 | 2021 | 94 | 1.900 |
Why?
|
| Biomarkers | 8 | 2021 | 54 | 1.900 |
Why?
|
| Transforming Growth Factor beta | 13 | 2014 | 17 | 1.860 |
Why?
|
| Mice | 17 | 2023 | 209 | 1.830 |
Why?
|
| Implants, Experimental | 6 | 2021 | 12 | 1.790 |
Why?
|
| Hip Prosthesis | 29 | 2021 | 32 | 1.750 |
Why?
|
| Bone Development | 11 | 2023 | 15 | 1.710 |
Why?
|
| Cartilage, Articular | 13 | 2017 | 31 | 1.680 |
Why?
|
| Titanium | 25 | 2021 | 31 | 1.490 |
Why?
|
| Arthroplasty, Replacement, Hip | 7 | 2021 | 11 | 1.280 |
Why?
|
| Osteoarthritis | 12 | 2021 | 44 | 1.240 |
Why?
|
| Prosthesis Failure | 11 | 2021 | 18 | 1.220 |
Why?
|
| Bone Morphogenetic Proteins | 5 | 2015 | 8 | 1.180 |
Why?
|
| Calcium, Dietary | 2 | 2018 | 5 | 1.110 |
Why?
|
| Tibia | 16 | 2014 | 23 | 1.020 |
Why?
|
| Aging | 5 | 2018 | 75 | 1.000 |
Why?
|
| Antibodies | 3 | 2015 | 10 | 0.940 |
Why?
|
| Endothelial Cells | 2 | 2023 | 6 | 0.930 |
Why?
|
| Glycoproteins | 2 | 2015 | 13 | 0.910 |
Why?
|
| Calcification, Physiologic | 6 | 2019 | 10 | 0.910 |
Why?
|
| Models, Animal | 15 | 2015 | 25 | 0.910 |
Why?
|
| Osteocalcin | 4 | 2021 | 12 | 0.880 |
Why?
|
| Aged | 26 | 2021 | 414 | 0.880 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 26 | 0.870 |
Why?
|
| Premature Birth | 1 | 2024 | 4 | 0.870 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2024 | 9 | 0.870 |
Why?
|
| Bone Marrow | 7 | 2023 | 12 | 0.870 |
Why?
|
| Middle Aged | 33 | 2021 | 488 | 0.840 |
Why?
|
| Cartilage | 4 | 2022 | 12 | 0.830 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2018 | 11 | 0.820 |
Why?
|
| Reoperation | 7 | 2021 | 8 | 0.810 |
Why?
|
| Bone Resorption | 11 | 2015 | 15 | 0.800 |
Why?
|
| Biomechanical Phenomena | 19 | 2020 | 52 | 0.790 |
Why?
|
| Circadian Clocks | 1 | 2022 | 5 | 0.780 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 19 | 0.770 |
Why?
|
| Inflammation | 2 | 2020 | 17 | 0.740 |
Why?
|
| Fractures, Bone | 3 | 2020 | 14 | 0.740 |
Why?
|
| Racism | 1 | 2022 | 4 | 0.740 |
Why?
|
| Collagen Type I | 2 | 2021 | 4 | 0.730 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2021 | 1 | 0.730 |
Why?
|
| Lactation | 2 | 2018 | 4 | 0.720 |
Why?
|
| Dogs | 36 | 2007 | 57 | 0.720 |
Why?
|
| Body Weight | 4 | 2019 | 14 | 0.720 |
Why?
|
| Bone Marrow Cells | 7 | 2015 | 17 | 0.700 |
Why?
|
| Biocompatible Materials | 8 | 2007 | 11 | 0.680 |
Why?
|
| Prosthesis-Related Infections | 2 | 2020 | 4 | 0.680 |
Why?
|
| Fracture Healing | 4 | 2014 | 9 | 0.670 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 3 | 0.670 |
Why?
|
| Models, Genetic | 1 | 2020 | 3 | 0.670 |
Why?
|
| Humerus | 7 | 2014 | 10 | 0.640 |
Why?
|
| Stromal Cells | 5 | 2015 | 9 | 0.630 |
Why?
|
| Contrast Media | 2 | 2017 | 9 | 0.630 |
Why?
|
| Microscopy, Electron, Scanning | 15 | 2017 | 17 | 0.630 |
Why?
|
| Minerals | 3 | 2018 | 4 | 0.600 |
Why?
|
| Tomography, X-Ray Computed | 13 | 2012 | 69 | 0.600 |
Why?
|
| Hip Joint | 10 | 2004 | 16 | 0.600 |
Why?
|
| Materials Testing | 8 | 2012 | 16 | 0.590 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2018 | 3 | 0.590 |
Why?
|
| Weaning | 1 | 2018 | 2 | 0.590 |
Why?
|
| Parathyroid Hormone | 2 | 2015 | 7 | 0.580 |
Why?
|
| Kidney | 1 | 2018 | 10 | 0.580 |
Why?
|
| Adipose Tissue | 1 | 2018 | 6 | 0.580 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 7 | 0.580 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 53 | 0.570 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 80 | 0.560 |
Why?
|
| Bone Morphogenetic Protein 2 | 7 | 2015 | 10 | 0.560 |
Why?
|
| Mice, Inbred C57BL | 5 | 2017 | 52 | 0.560 |
Why?
|
| Polyethylene | 2 | 2019 | 5 | 0.550 |
Why?
|
| Calcium Phosphates | 5 | 2005 | 7 | 0.550 |
Why?
|
| Aged, 80 and over | 13 | 2021 | 209 | 0.540 |
Why?
|
| Cortical Bone | 1 | 2017 | 2 | 0.530 |
Why?
|
| Osteoarthritis, Knee | 5 | 2010 | 19 | 0.530 |
Why?
|
| Coated Materials, Biocompatible | 3 | 2007 | 6 | 0.520 |
Why?
|
| Genetic Markers | 2 | 2015 | 6 | 0.510 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2016 | 1 | 0.500 |
Why?
|
| Radiography | 17 | 2018 | 35 | 0.490 |
Why?
|
| Mutation | 1 | 2016 | 63 | 0.490 |
Why?
|
| Adult | 26 | 2010 | 551 | 0.480 |
Why?
|
| Gene Expression Profiling | 5 | 2010 | 11 | 0.480 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2011 | 6 | 0.470 |
Why?
|
| Acetabulum | 7 | 2005 | 11 | 0.450 |
Why?
|
| Gait | 9 | 2014 | 16 | 0.440 |
Why?
|
| Gene Expression | 5 | 2013 | 27 | 0.430 |
Why?
|
| Phenotype | 3 | 2022 | 50 | 0.430 |
Why?
|
| Knee Prosthesis | 7 | 2014 | 8 | 0.430 |
Why?
|
| Cell Movement | 3 | 2012 | 10 | 0.420 |
Why?
|
| Knee Joint | 7 | 2014 | 15 | 0.420 |
Why?
|
| Metals | 3 | 2011 | 5 | 0.410 |
Why?
|
| Time Factors | 16 | 2021 | 143 | 0.410 |
Why?
|
| Heterocyclic Compounds | 2 | 2012 | 2 | 0.410 |
Why?
|
| Prosthesis Implantation | 3 | 2012 | 5 | 0.410 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2012 | 1 | 0.390 |
Why?
|
| Adult Stem Cells | 1 | 2012 | 1 | 0.390 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 6 | 0.390 |
Why?
|
| Running | 1 | 2012 | 1 | 0.380 |
Why?
|
| Prosthesis Design | 18 | 2005 | 21 | 0.370 |
Why?
|
| Mice, Knockout | 4 | 2022 | 39 | 0.370 |
Why?
|
| Osteoblasts | 5 | 2015 | 12 | 0.370 |
Why?
|
| Mechanical Phenomena | 1 | 2011 | 4 | 0.360 |
Why?
|
| Electron Microscope Tomography | 1 | 2011 | 2 | 0.360 |
Why?
|
| Ultrasonic Therapy | 4 | 2014 | 5 | 0.360 |
Why?
|
| Polymers | 3 | 2007 | 5 | 0.350 |
Why?
|
| Weight-Bearing | 7 | 2010 | 13 | 0.340 |
Why?
|
| Porosity | 8 | 2018 | 14 | 0.330 |
Why?
|
| Stress, Mechanical | 16 | 2007 | 26 | 0.330 |
Why?
|
| Recombinant Proteins | 11 | 2014 | 33 | 0.330 |
Why?
|
| Cell Differentiation | 4 | 2020 | 31 | 0.330 |
Why?
|
| Surface Properties | 8 | 2019 | 17 | 0.320 |
Why?
|
| Adaptation, Physiological | 5 | 2001 | 16 | 0.320 |
Why?
|
| Durapatite | 3 | 2005 | 4 | 0.300 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2014 | 60 | 0.300 |
Why?
|
| Bone Screws | 5 | 2021 | 10 | 0.300 |
Why?
|
| Diphosphonates | 2 | 2014 | 6 | 0.290 |
Why?
|
| Mice, Transgenic | 4 | 2023 | 24 | 0.290 |
Why?
|
| Ultrasonics | 2 | 2005 | 2 | 0.290 |
Why?
|
| Tissue Engineering | 2 | 2007 | 5 | 0.290 |
Why?
|
| Biomimetic Materials | 2 | 2006 | 3 | 0.280 |
Why?
|
| Regeneration | 3 | 2015 | 5 | 0.280 |
Why?
|
| Models, Biological | 8 | 2014 | 99 | 0.280 |
Why?
|
| Osteocytes | 3 | 2014 | 5 | 0.280 |
Why?
|
| Range of Motion, Articular | 2 | 2006 | 15 | 0.280 |
Why?
|
| Alkaline Phosphatase | 3 | 2024 | 8 | 0.270 |
Why?
|
| Bone Transplantation | 5 | 2004 | 6 | 0.270 |
Why?
|
| Bone Cements | 9 | 1996 | 9 | 0.260 |
Why?
|
| Infant, Newborn | 3 | 2024 | 55 | 0.260 |
Why?
|
| Polyethyleneimine | 3 | 2015 | 6 | 0.260 |
Why?
|
| Bone Nails | 4 | 2006 | 4 | 0.260 |
Why?
|
| Ovariectomy | 3 | 2021 | 6 | 0.260 |
Why?
|
| Calcium | 2 | 2018 | 189 | 0.250 |
Why?
|
| Mandible | 4 | 2007 | 4 | 0.250 |
Why?
|
| Osteogenesis, Distraction | 4 | 2007 | 4 | 0.250 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2016 | 2 | 0.250 |
Why?
|
| Tissue Scaffolds | 3 | 2015 | 7 | 0.240 |
Why?
|
| Signal Transduction | 4 | 2020 | 72 | 0.240 |
Why?
|
| Risk Assessment | 2 | 2018 | 36 | 0.240 |
Why?
|
| Sodium Chloride | 1 | 2005 | 7 | 0.240 |
Why?
|
| Absorptiometry, Photon | 8 | 2006 | 13 | 0.230 |
Why?
|
| Swine | 2 | 2024 | 9 | 0.230 |
Why?
|
| Ioxaglic Acid | 2 | 2017 | 3 | 0.230 |
Why?
|
| Collagen | 5 | 2016 | 21 | 0.230 |
Why?
|
| Anabolic Agents | 1 | 2004 | 2 | 0.230 |
Why?
|
| Graft Survival | 1 | 2004 | 8 | 0.230 |
Why?
|
| Skull | 2 | 2015 | 6 | 0.220 |
Why?
|
| Lumbar Vertebrae | 4 | 2014 | 25 | 0.220 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 4 | 0.220 |
Why?
|
| Animals, Newborn | 1 | 2024 | 10 | 0.220 |
Why?
|
| Infant, Premature | 1 | 2024 | 14 | 0.220 |
Why?
|
| Cells, Cultured | 8 | 2011 | 88 | 0.220 |
Why?
|
| Regression Analysis | 4 | 2016 | 17 | 0.220 |
Why?
|
| Bone Diseases, Metabolic | 2 | 2021 | 7 | 0.210 |
Why?
|
| Alloys | 7 | 2004 | 8 | 0.200 |
Why?
|
| Hip | 4 | 2000 | 5 | 0.200 |
Why?
|
| Physicians | 1 | 2023 | 12 | 0.200 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2023 | 3 | 0.200 |
Why?
|
| Epithelial Cells | 1 | 2022 | 2 | 0.200 |
Why?
|
| ARNTL Transcription Factors | 1 | 2022 | 2 | 0.200 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 4 | 2009 | 6 | 0.200 |
Why?
|
| Random Allocation | 2 | 2012 | 12 | 0.200 |
Why?
|
| Joint Prosthesis | 2 | 2020 | 5 | 0.190 |
Why?
|
| Anatomy | 1 | 2023 | 25 | 0.190 |
Why?
|
| Age Factors | 2 | 2021 | 51 | 0.190 |
Why?
|
| Circadian Rhythm | 1 | 2022 | 43 | 0.190 |
Why?
|
| Receptors, CXCR4 | 2 | 2012 | 4 | 0.190 |
Why?
|
| Risk Factors | 2 | 2021 | 140 | 0.190 |
Why?
|
| Cartilage Diseases | 1 | 2002 | 1 | 0.190 |
Why?
|
| Talus | 1 | 2002 | 1 | 0.190 |
Why?
|
| Imidazoles | 1 | 2002 | 12 | 0.190 |
Why?
|
| Wound Healing | 3 | 2015 | 6 | 0.180 |
Why?
|
| Sweden | 1 | 2021 | 1 | 0.180 |
Why?
|
| Photogrammetry | 1 | 2001 | 1 | 0.180 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 59 | 0.180 |
Why?
|
| Spinal Fusion | 3 | 1995 | 10 | 0.180 |
Why?
|
| Registries | 1 | 2021 | 14 | 0.180 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2015 | 9 | 0.180 |
Why?
|
| Immunoassay | 1 | 2021 | 4 | 0.180 |
Why?
|
| United States | 1 | 2022 | 155 | 0.180 |
Why?
|
| Palatal Expansion Technique | 1 | 2021 | 1 | 0.180 |
Why?
|
| Orthodontic Anchorage Procedures | 1 | 2021 | 1 | 0.180 |
Why?
|
| Cancellous Bone | 1 | 2021 | 2 | 0.180 |
Why?
|
| Pilot Projects | 5 | 2015 | 29 | 0.170 |
Why?
|
| Transforming Growth Factor beta2 | 3 | 2005 | 4 | 0.170 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2001 | 1 | 0.170 |
Why?
|
| Computer Simulation | 4 | 2000 | 31 | 0.170 |
Why?
|
| Metatarsus | 1 | 2000 | 1 | 0.170 |
Why?
|
| Plasmids | 3 | 2015 | 10 | 0.170 |
Why?
|
| Fracture Fixation | 2 | 2014 | 5 | 0.170 |
Why?
|
| Bone-Implant Interface | 1 | 2020 | 3 | 0.170 |
Why?
|
| Prosthesis Retention | 1 | 2020 | 3 | 0.170 |
Why?
|
| Vitallium | 2 | 2011 | 2 | 0.170 |
Why?
|
| Movement | 5 | 2006 | 11 | 0.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2011 | 21 | 0.160 |
Why?
|
| Osteoarthritis, Hip | 2 | 2001 | 2 | 0.160 |
Why?
|
| NF-kappa B | 1 | 2020 | 5 | 0.160 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 7 | 0.160 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 5 | 0.160 |
Why?
|
| Cobalt | 2 | 2014 | 4 | 0.160 |
Why?
|
| Motor Activity | 1 | 2019 | 20 | 0.160 |
Why?
|
| Hindlimb | 3 | 2012 | 4 | 0.150 |
Why?
|
| Treatment Outcome | 5 | 2012 | 118 | 0.150 |
Why?
|
| Femur Neck | 1 | 1999 | 3 | 0.150 |
Why?
|
| Joints | 3 | 2005 | 8 | 0.150 |
Why?
|
| Independent Living | 1 | 2018 | 11 | 0.150 |
Why?
|
| Memory, Short-Term | 1 | 2018 | 14 | 0.150 |
Why?
|
| Phosphates | 1 | 2018 | 6 | 0.150 |
Why?
|
| Comorbidity | 1 | 2018 | 27 | 0.150 |
Why?
|
| Prognosis | 1 | 2018 | 28 | 0.150 |
Why?
|
| Prevalence | 1 | 2018 | 26 | 0.150 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 13 | 0.150 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 36 | 0.150 |
Why?
|
| Double-Blind Method | 1 | 2018 | 37 | 0.150 |
Why?
|
| Pregnancy | 1 | 2018 | 44 | 0.150 |
Why?
|
| Mice, Inbred BALB C | 2 | 2015 | 12 | 0.150 |
Why?
|
| X-Rays | 2 | 2016 | 3 | 0.140 |
Why?
|
| Synchrotrons | 2 | 2009 | 2 | 0.140 |
Why?
|
| Cell Proliferation | 3 | 2013 | 19 | 0.140 |
Why?
|
| Microscopy, Fluorescence | 2 | 2014 | 12 | 0.140 |
Why?
|
| Trypsin | 1 | 2017 | 3 | 0.130 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 4 | 0.130 |
Why?
|
| Rabbits | 6 | 2015 | 52 | 0.130 |
Why?
|
| Gene Transfer Techniques | 2 | 2015 | 9 | 0.130 |
Why?
|
| Tensile Strength | 2 | 2012 | 2 | 0.130 |
Why?
|
| Proteoglycans | 4 | 2008 | 11 | 0.130 |
Why?
|
| Point Mutation | 1 | 2016 | 9 | 0.130 |
Why?
|
| Genotype | 1 | 2016 | 37 | 0.120 |
Why?
|
| Femoral Fractures | 2 | 2006 | 3 | 0.120 |
Why?
|
| Temporal Bone | 2 | 2006 | 2 | 0.120 |
Why?
|
| Mandibular Condyle | 2 | 2006 | 3 | 0.120 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2006 | 18 | 0.120 |
Why?
|
| Spinal Diseases | 1 | 1995 | 2 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 6 | 0.120 |
Why?
|
| Benzylamines | 2 | 2012 | 7 | 0.120 |
Why?
|
| RNA | 1 | 2015 | 3 | 0.120 |
Why?
|
| Wnt Proteins | 2 | 2012 | 4 | 0.120 |
Why?
|
| Arthroplasty, Subchondral | 1 | 2015 | 2 | 0.120 |
Why?
|
| Shoulder | 1 | 2015 | 3 | 0.120 |
Why?
|
| Periosteum | 2 | 2012 | 3 | 0.120 |
Why?
|
| Chondrogenesis | 1 | 2015 | 10 | 0.120 |
Why?
|
| DNA Primers | 2 | 2005 | 9 | 0.120 |
Why?
|
| RNA, Messenger | 2 | 2005 | 38 | 0.120 |
Why?
|
| Mice, Inbred Strains | 1 | 2015 | 3 | 0.120 |
Why?
|
| Mice, Inbred C3H | 1 | 2015 | 4 | 0.120 |
Why?
|
| Down-Regulation | 2 | 2005 | 19 | 0.120 |
Why?
|
| Species Specificity | 1 | 2015 | 8 | 0.120 |
Why?
|
| Growth Substances | 2 | 2005 | 2 | 0.120 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 60 | 0.110 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2015 | 6 | 0.110 |
Why?
|
| Nickel | 1 | 2014 | 3 | 0.110 |
Why?
|
| Copper | 1 | 2014 | 6 | 0.110 |
Why?
|
| Chitosan | 1 | 2014 | 3 | 0.110 |
Why?
|
| Microvessels | 1 | 2014 | 3 | 0.110 |
Why?
|
| Walking | 5 | 2014 | 6 | 0.110 |
Why?
|
| Corpus Striatum | 1 | 2014 | 10 | 0.110 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2014 | 5 | 0.110 |
Why?
|
| Methamphetamine | 1 | 2014 | 5 | 0.110 |
Why?
|
| Cementation | 6 | 1997 | 6 | 0.110 |
Why?
|
| Diaphyses | 1 | 2014 | 3 | 0.110 |
Why?
|
| Organ Specificity | 1 | 2014 | 3 | 0.110 |
Why?
|
| Macaca fascicularis | 1 | 2014 | 3 | 0.110 |
Why?
|
| Osteoporotic Fractures | 1 | 2014 | 4 | 0.110 |
Why?
|
| Calcitonin | 1 | 2014 | 5 | 0.110 |
Why?
|
| Bone Density Conservation Agents | 1 | 2014 | 5 | 0.110 |
Why?
|
| Reference Values | 2 | 2012 | 21 | 0.110 |
Why?
|
| Etidronic Acid | 2 | 2004 | 2 | 0.110 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2014 | 7 | 0.110 |
Why?
|
| Alendronate | 2 | 2004 | 3 | 0.110 |
Why?
|
| Polyethylenes | 4 | 1998 | 4 | 0.100 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2013 | 2 | 0.100 |
Why?
|
| Ossification, Heterotopic | 4 | 2009 | 4 | 0.100 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 7 | 0.100 |
Why?
|
| Adolescent | 4 | 2002 | 187 | 0.100 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2012 | 1 | 0.100 |
Why?
|
| Colony-Forming Units Assay | 1 | 2012 | 2 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2012 | 13 | 0.100 |
Why?
|
| Chemokine CXCL12 | 1 | 2012 | 1 | 0.090 |
Why?
|
| Matrix Metalloproteinases | 2 | 2010 | 4 | 0.090 |
Why?
|
| NFATC Transcription Factors | 1 | 2011 | 2 | 0.090 |
Why?
|
| Calcineurin | 1 | 2011 | 3 | 0.090 |
Why?
|
| Metatarsal Bones | 2 | 2003 | 2 | 0.090 |
Why?
|
| Gap Junctions | 1 | 2011 | 1 | 0.090 |
Why?
|
| Cell Communication | 1 | 2011 | 5 | 0.090 |
Why?
|
| Spinal Cord | 1 | 2010 | 7 | 0.080 |
Why?
|
| DNA | 3 | 2015 | 21 | 0.080 |
Why?
|
| Equipment Design | 4 | 2010 | 10 | 0.080 |
Why?
|
| Ganglia, Spinal | 1 | 2010 | 12 | 0.080 |
Why?
|
| Rats, Inbred F344 | 3 | 2015 | 7 | 0.080 |
Why?
|
| Nociceptors | 1 | 2010 | 7 | 0.080 |
Why?
|
| Matrix Metalloproteinase 13 | 2 | 2007 | 2 | 0.080 |
Why?
|
| Arthralgia | 1 | 2010 | 12 | 0.080 |
Why?
|
| Quadriceps Muscle | 1 | 2010 | 1 | 0.080 |
Why?
|
| Knee | 1 | 2010 | 2 | 0.080 |
Why?
|
| Exercise Therapy | 1 | 2010 | 5 | 0.080 |
Why?
|
| Fracture Fixation, Internal | 1 | 1990 | 2 | 0.080 |
Why?
|
| Elasticity | 5 | 2001 | 11 | 0.080 |
Why?
|
| Scattering, Radiation | 2 | 2009 | 8 | 0.080 |
Why?
|
| Pan troglodytes | 1 | 1989 | 1 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 6 | 0.080 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2008 | 5 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 12 | 0.070 |
Why?
|
| Up-Regulation | 2 | 2007 | 10 | 0.070 |
Why?
|
| Follow-Up Studies | 3 | 2005 | 69 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2015 | 22 | 0.070 |
Why?
|
| Equipment Failure Analysis | 2 | 2006 | 6 | 0.070 |
Why?
|
| Hemarthrosis | 1 | 2008 | 3 | 0.070 |
Why?
|
| Hemophilia A | 1 | 2008 | 10 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2008 | 2 | 0.070 |
Why?
|
| Cell Line | 3 | 2014 | 43 | 0.070 |
Why?
|
| Stem Cell Transplantation | 1 | 2007 | 2 | 0.070 |
Why?
|
| Craniosynostoses | 1 | 2007 | 2 | 0.070 |
Why?
|
| Cell Lineage | 1 | 2007 | 5 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2007 | 7 | 0.070 |
Why?
|
| Chromium Alloys | 2 | 2005 | 4 | 0.070 |
Why?
|
| Acrylic Resins | 1 | 2007 | 1 | 0.070 |
Why?
|
| Hydroxyapatites | 2 | 2005 | 2 | 0.070 |
Why?
|
| Temporomandibular Joint | 1 | 2007 | 3 | 0.070 |
Why?
|
| Guided Tissue Regeneration | 1 | 2006 | 1 | 0.070 |
Why?
|
| Extracellular Matrix | 1 | 2006 | 5 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2003 | 119 | 0.060 |
Why?
|
| Posture | 1 | 2006 | 4 | 0.060 |
Why?
|
| X-Ray Diffraction | 1 | 2006 | 1 | 0.060 |
Why?
|
| Models, Anatomic | 1 | 2006 | 8 | 0.060 |
Why?
|
| Radiographic Image Enhancement | 2 | 2004 | 2 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2006 | 35 | 0.060 |
Why?
|
| Locomotion | 1 | 2005 | 2 | 0.060 |
Why?
|
| Principal Component Analysis | 1 | 2005 | 1 | 0.060 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 4 | 0.060 |
Why?
|
| In Vitro Techniques | 3 | 2006 | 67 | 0.060 |
Why?
|
| Cattle | 2 | 2021 | 14 | 0.060 |
Why?
|
| Chymopapain | 2 | 2003 | 2 | 0.060 |
Why?
|
| Shear Strength | 1 | 2005 | 3 | 0.060 |
Why?
|
| Delayed-Action Preparations | 1 | 2005 | 4 | 0.060 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2005 | 1 | 0.060 |
Why?
|
| Orthopedics | 1 | 2005 | 1 | 0.060 |
Why?
|
| Algorithms | 2 | 2014 | 42 | 0.060 |
Why?
|
| Base Sequence | 1 | 2005 | 17 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 10 | 0.060 |
Why?
|
| Evaluation Studies as Topic | 2 | 1997 | 4 | 0.060 |
Why?
|
| Bone Marrow Purging | 1 | 2004 | 1 | 0.060 |
Why?
|
| Cell Survival | 2 | 2015 | 13 | 0.060 |
Why?
|
| Genetic Therapy | 2 | 2015 | 16 | 0.060 |
Why?
|
| Temperature | 1 | 2004 | 11 | 0.050 |
Why?
|
| Jogging | 1 | 2004 | 1 | 0.050 |
Why?
|
| Orthopedic Fixation Devices | 2 | 2014 | 5 | 0.050 |
Why?
|
| Growth Plate | 1 | 2003 | 2 | 0.050 |
Why?
|
| Professionalism | 1 | 2023 | 1 | 0.050 |
Why?
|
| Personal Autonomy | 1 | 2023 | 1 | 0.050 |
Why?
|
| Ankle Joint | 1 | 2003 | 1 | 0.050 |
Why?
|
| Anthropometry | 1 | 2003 | 7 | 0.050 |
Why?
|
| Protective Agents | 1 | 2003 | 1 | 0.050 |
Why?
|
| Hyaluronic Acid | 1 | 2003 | 2 | 0.050 |
Why?
|
| Attitude of Health Personnel | 1 | 2023 | 14 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2023 | 2 | 0.050 |
Why?
|
| Amino Acids | 1 | 2002 | 1 | 0.050 |
Why?
|
| Transplantation, Autologous | 3 | 2007 | 3 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2002 | 43 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2014 | 20 | 0.050 |
Why?
|
| Rats, Zucker | 1 | 2021 | 2 | 0.040 |
Why?
|
| Child, Preschool | 2 | 1996 | 87 | 0.040 |
Why?
|
| Infant | 2 | 1996 | 89 | 0.040 |
Why?
|
| Palate | 1 | 2021 | 1 | 0.040 |
Why?
|
| Child | 2 | 1996 | 156 | 0.040 |
Why?
|
| Ilium | 1 | 2001 | 1 | 0.040 |
Why?
|
| Surgical Instruments | 1 | 2001 | 1 | 0.040 |
Why?
|
| Wrist Joint | 1 | 2001 | 1 | 0.040 |
Why?
|
| Radiation Dosage | 2 | 2011 | 5 | 0.040 |
Why?
|
| Radius | 1 | 2001 | 2 | 0.040 |
Why?
|
| Elbow Joint | 1 | 2001 | 2 | 0.040 |
Why?
|
| Sex Factors | 4 | 2003 | 42 | 0.040 |
Why?
|
| Arthroplasty, Replacement | 1 | 2020 | 3 | 0.040 |
Why?
|
| Finite Element Analysis | 1 | 2000 | 2 | 0.040 |
Why?
|
| Analysis of Variance | 4 | 2007 | 22 | 0.040 |
Why?
|
| Osteoclasts | 1 | 2020 | 2 | 0.040 |
Why?
|
| Chi-Square Distribution | 3 | 2007 | 9 | 0.040 |
Why?
|
| Transplantation, Homologous | 3 | 1996 | 5 | 0.040 |
Why?
|
| Mechanics | 1 | 1998 | 2 | 0.040 |
Why?
|
| Arthrography | 1 | 1998 | 2 | 0.040 |
Why?
|
| Microradiography | 2 | 2005 | 2 | 0.040 |
Why?
|
| Software | 1 | 1998 | 6 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2010 | 9 | 0.030 |
Why?
|
| Oligopeptides | 2 | 2007 | 5 | 0.030 |
Why?
|
| Sialoglycoproteins | 2 | 2007 | 2 | 0.030 |
Why?
|
| Craniocerebral Trauma | 1 | 2015 | 3 | 0.030 |
Why?
|
| Collagen Type III | 1 | 2015 | 1 | 0.030 |
Why?
|
| Foreign Bodies | 1 | 1995 | 7 | 0.030 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2014 | 1 | 0.030 |
Why?
|
| Molybdenum | 1 | 2014 | 1 | 0.030 |
Why?
|
| Chromium | 1 | 2014 | 2 | 0.030 |
Why?
|
| Cell Death | 1 | 2014 | 3 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 8 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 2 | 0.030 |
Why?
|
| Hypoxia | 1 | 2014 | 3 | 0.030 |
Why?
|
| Receptors, Endothelin | 1 | 2014 | 3 | 0.030 |
Why?
|
| Self Administration | 1 | 2014 | 4 | 0.030 |
Why?
|
| Vasoconstriction | 1 | 2014 | 3 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2014 | 5 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2014 | 10 | 0.030 |
Why?
|
| Hardness | 1 | 1994 | 1 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1994 | 2 | 0.030 |
Why?
|
| Rotation | 1 | 1994 | 8 | 0.030 |
Why?
|
| Thiophenes | 1 | 2014 | 4 | 0.030 |
Why?
|
| Physical Examination | 1 | 2014 | 7 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2013 | 9 | 0.030 |
Why?
|
| Transfection | 1 | 2013 | 19 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 25 | 0.030 |
Why?
|
| Calcineurin Inhibitors | 1 | 2011 | 1 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 17 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2011 | 6 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 26 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2010 | 3 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 2 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 19 | 0.020 |
Why?
|
| Transducers | 1 | 2010 | 3 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2010 | 23 | 0.020 |
Why?
|
| Chondrocytes | 1 | 2010 | 16 | 0.020 |
Why?
|
| Arthritis, Experimental | 1 | 2010 | 8 | 0.020 |
Why?
|
| Muscle Strength | 1 | 2010 | 2 | 0.020 |
Why?
|
| Histological Techniques | 1 | 1990 | 2 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 1990 | 14 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2010 | 27 | 0.020 |
Why?
|
| Pain Management | 1 | 2010 | 15 | 0.020 |
Why?
|
| Pain | 1 | 2010 | 25 | 0.020 |
Why?
|
| Normal Distribution | 1 | 2009 | 1 | 0.020 |
Why?
|
| Absorption | 1 | 2009 | 2 | 0.020 |
Why?
|
| Silicon | 1 | 2009 | 3 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2009 | 1 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2009 | 8 | 0.020 |
Why?
|
| Apoptosis | 1 | 2009 | 24 | 0.020 |
Why?
|
| Air | 1 | 1989 | 2 | 0.020 |
Why?
|
| Ethanol | 1 | 1989 | 2 | 0.020 |
Why?
|
| Water | 1 | 1989 | 6 | 0.020 |
Why?
|
| Synovitis | 1 | 2008 | 3 | 0.020 |
Why?
|
| Factor VIII | 1 | 2008 | 7 | 0.020 |
Why?
|
| Sampling Studies | 1 | 1988 | 3 | 0.020 |
Why?
|
| Research Design | 1 | 1988 | 16 | 0.020 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2007 | 1 | 0.020 |
Why?
|
| Osteotomy | 1 | 2007 | 4 | 0.020 |
Why?
|
| Cadaver | 2 | 1998 | 21 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2007 | 63 | 0.020 |
Why?
|
| Muscle, Skeletal | 2 | 1998 | 66 | 0.020 |
Why?
|
| Acrylates | 1 | 2007 | 1 | 0.020 |
Why?
|
| Ethylene Glycol | 1 | 2007 | 1 | 0.020 |
Why?
|
| Dactinomycin | 1 | 2007 | 1 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2007 | 1 | 0.020 |
Why?
|
| Growth Differentiation Factor 5 | 1 | 2007 | 1 | 0.020 |
Why?
|
| Cycloheximide | 1 | 2007 | 2 | 0.020 |
Why?
|
| Biomimetics | 1 | 2006 | 3 | 0.020 |
Why?
|
| Autoanalysis | 1 | 1985 | 1 | 0.010 |
Why?
|
| Paleontology | 1 | 1985 | 1 | 0.010 |
Why?
|
| Mandibular Nerve | 1 | 2005 | 1 | 0.010 |
Why?
|
| Internal Fixators | 1 | 2005 | 3 | 0.010 |
Why?
|
| Osteonectin | 1 | 2005 | 1 | 0.010 |
Why?
|
| Genes, myc | 1 | 2005 | 1 | 0.010 |
Why?
|
| Genes, jun | 1 | 2005 | 1 | 0.010 |
Why?
|
| Immediate-Early Proteins | 1 | 2005 | 1 | 0.010 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2005 | 1 | 0.010 |
Why?
|
| Osteopontin | 1 | 2005 | 1 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2005 | 2 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 2 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2005 | 5 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2005 | 33 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 21 | 0.010 |
Why?
|
| Fetus | 1 | 1984 | 2 | 0.010 |
Why?
|
| Mathematics | 1 | 1984 | 18 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2003 | 1 | 0.010 |
Why?
|
| Lectins, C-Type | 1 | 2003 | 1 | 0.010 |
Why?
|
| Decorin | 1 | 2003 | 1 | 0.010 |
Why?
|
| Biglycan | 1 | 2003 | 1 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2003 | 2 | 0.010 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2003 | 3 | 0.010 |
Why?
|
| Aggrecans | 1 | 2003 | 3 | 0.010 |
Why?
|
| Compressive Strength | 1 | 2003 | 3 | 0.010 |
Why?
|
| Keratan Sulfate | 1 | 2003 | 1 | 0.010 |
Why?
|
| Viscosity | 1 | 2003 | 1 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2003 | 20 | 0.010 |
Why?
|
| Injections, Intra-Articular | 1 | 2003 | 3 | 0.010 |
Why?
|
| Postoperative Complications | 2 | 1993 | 23 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2000 | 80 | 0.010 |
Why?
|
| Forecasting | 1 | 1998 | 9 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 1998 | 37 | 0.010 |
Why?
|
| Calibration | 1 | 1998 | 2 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 1997 | 1 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 1997 | 10 | 0.010 |
Why?
|
| Microscopy, Polarization | 1 | 1996 | 1 | 0.010 |
Why?
|
| Autopsy | 1 | 1996 | 12 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 1996 | 102 | 0.010 |
Why?
|
| Foreign-Body Migration | 1 | 1995 | 1 | 0.010 |
Why?
|
| Fibrosis | 1 | 1995 | 4 | 0.010 |
Why?
|
| Methods | 1 | 1993 | 3 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1993 | 3 | 0.010 |
Why?
|
| Postoperative Period | 1 | 1993 | 4 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1992 | 10 | 0.010 |
Why?
|
| Cryopreservation | 1 | 1992 | 2 | 0.010 |
Why?
|
| Metallurgy | 1 | 1986 | 1 | 0.000 |
Why?
|